Fine-Needle Aspiration of the Thyroid Gland
- PMID: 25905400
- Bookshelf ID: NBK285544
Fine-Needle Aspiration of the Thyroid Gland
Excerpt
Thyroid nodules are common in clinical practice and the majority are benign with the risk of malignancy varying from 7 to 15%. Clinical evaluation includes careful history and physical examination, laboratory tests, neck ultrasound (US), and a fine-needle aspiration (FNA). Thyroid FNA or biopsy is an accurate test for determining malignancy in a nodule and is an integral part of current thyroid nodule evaluation. Results are superior when FNA is performed with ultrasound-guidance (USFNA). Herein, we describe techniques used for US-guided FNA. FNA results are classified as diagnostic (satisfactory) or nondiagnostic (unsatisfactory). Unsatisfactory smears (5-10%) result from hypocellular specimens usually caused by cystic fluid, bloody smears, or suboptimal preparation. Diagnostic smears are conventionally classified into benign, indeterminate, or malignant. A benign cytology is negative for malignancy, and includes cysts, colloid nodule, or Hashimoto thyroiditis. Malignant (or suspicious for malignancy) cytology is usually positive for malignancy on histology, and includes primary thyroid tumors or, less frequently, nonthyroidal metastatic cancers. Papillary thyroid carcinoma (PTC) is the most common malignancy, characterized by increased cellularity, sheets of cells, and typical nuclear abnormalities. Indeterminate or suspicious specimens include atypical changes, Hürthle (oncocytic) cells or follicular neoplasms, typically with absent or scant colloid, hypercellularity, and sometimes a microfollicular arrangement. The Bethesda Cytologic Classification has a 6-category classification. Overall, the indeterminate category Bethesda III category has a risk of malignancy of 6-18% if Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is not considered cancer. Advances in molecular testing can help further separate benign from malignant nodules with an indeterminate cytology. For complete coverage of all related areas of Endocrinology, please visit our on-line FREE web-text,
Copyright © 2000-2025, MDText.com, Inc.
Sections
- ABSTRACT
- INTRODUCTION
- DEFINITIONS/HISTORY
- EQUIPMENT
- THE PATIENT
- THE TECHNIQUES
- POST BIOPSY PROCEDURE
- COMPLICATIONS
- CYTOLOGIC DIAGNOSIS
- FNA RESULTS
- DIAGNOSTIC ACCURACY
- FNA GUIDELINES
- US-FNA BIOPSY
- THYROID ULTRASOUND AND SONOGRAPHIC RISK STRATIFICATION SYSTEMS
- FNA PITFALLS
- RE-BIOPSY
- BETHESDA SYSTEM
- THE UTILITY OF MOLECULAR TESTING IN THYROUD FNA/BIOPSY
- THE USE OF US-GUIDED FNA WITH MINIMALLY INVASIVE THYROID PROCEDURES
- REFERENCES
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30. - PubMed
-
- Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clinic proceedings. 1994;69:44–49. - PubMed
-
- Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinology and metabolism clinics of North America. 2007;36:707–735. vi. - PubMed
-
- Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P 2010 American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 16:468-475. - PubMed
-
- Hegedüs L. Clinical practice. The thyroid nodule. The New England journal of medicine. 2004;351:1764–1771. - PubMed
Publication types
LinkOut - more resources
Full Text Sources